This scoping review identifies the first wave of randomized controlled trials testing large language models in digestive diseases. Four published and ten ongoing trials suggest that AI tools such as ...

VBDAs are significant contributors to stroke, and wall enhancement on vessel wall MRI (VW MRI) is considered a marker of inflammation and aneurysm vulnerability. While previous studies have shown that ...

Background Although multiple studies have offered self-collection for human papillomavirus (HPV)-based cervical screening in ...

Background The role of mineralocorticoid receptor antagonists (MRAs) in acute myocardial infarction (MI) remains controversial, with conflicting evidence from landmark trials. We aimed to assess the ...

DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID ...

The recent study was conducted to understand whether curcumin or turmeric supplements can help to improve systolic or ...

Introduction Population level screen and treat approach for anaemia reduction could be beneficial but its feasibility and ...

The FDA is raising the bar for approval of CAR T-cell therapies in oncology. Under plans outlined by the FDA’s biologics chief Vinay Prasad, M.D., the agency will require developers of many CAR-Ts to ...

Trials are essential to ruling out what doesn't work, as well as identifying what does Last year, we ran a randomised controlled trial working with ...

First Patient Dosed with Intranasal Foralumab in Randomized, Placebo-Controlled Phase 2 TrialBuilds on Recent Evidence of Persistent Neuroinflammation in Alzheimer’s Patients Treated with Anti-Amyloid ...

Introduction This article outlines the research protocol for a multicentre, randomised, controlled study designed to evaluate the therapeutic effect of a modified olfactory training (MOT) based on ...

This pivotal Phase III trial is designed to evaluate the efficacy and safety of Debio 4126, a novel long-acting octreotide formulation and the first potential 3-month somatostatin analogue (SSA), in ...